Skip Navigation

Phase I Multicenter, Open Label, Dose-Escalation Study to Determine The Maximum Tolerated Dose For Trichostatin A in Subjects With Relapsed or Refractory Hematologic Malignancies

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03838926

Study #:
STUDY00142788

Start Date:
May 12, 2015

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03838926

View Complete Trial Details & Eligibility at ClinicalTrials.gov